Issue Date: April 24, 2017
Fujifilm grows biomanufacturing
Fujifilm will invest $37 million to expand its biomanufacturing business in the U.S. and the U.K. In the U.S., Fujifilm Diosynth Biotechnologies will spend $28 million on mammalian cell bioreactors at a recently opened facility in College Station, Texas. Construction of the $92 million plant was partly financed by the U.S. Biomedical Advanced Research & Development Authority. In Billingham, England, Fujifilm Diosynth will spend $9 million to expand process development capabilities. Fujifilm acquired the Texas facility in 2014 and the Billingham plant in 2011.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society